Many See Hope in Parkinson’s Drug Pulled From Testing

“If a company stops developing a drug for safety or efficacy reasons, is it obligated to continue supplying it to patients from its clinical trials?”

Related posts:

1. Is the FDA killing research?
2. The FDA assault on quinine and guaifenesin
3. Is the pressure getting to Steven Nissen?
4. Don’t alter prescriptions
5. No more urine
6. Torcetrapib failed even worse than thought
7. Flaws in the Avandia study?

  Follow on Twitter   Subscribe

Tagged as: patient